Nextgen Biomed Ltd
Tel Aviv Stock Exchange NXGN.TA
Nextgen Biomed Ltd Price to Earnings Ratio (P/E) on January 14, 2025: -0.36
Nextgen Biomed Ltd Price to Earnings Ratio (P/E) is -0.36 on January 14, 2025, a 51.06% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
-
Nextgen Biomed Ltd 52-week high Price to Earnings Ratio (P/E) is -0.28 on January 02, 2025, which is 20.82% above the current Price to Earnings Ratio (P/E).
-
Nextgen Biomed Ltd 52-week low Price to Earnings Ratio (P/E) is -1.29 on December 20, 2024, which is -258.21% below the current Price to Earnings Ratio (P/E).
-
Nextgen Biomed Ltd average Price to Earnings Ratio (P/E) for the last 52 weeks is -0.46.
Key data
| Date | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) | Dividend Yield |
|---|
Market news
Loading...
Tel Aviv Stock Exchange: NXGN.TA
| CEO | Mr. Harel Hershtik |
| IPO Date | Aug. 12, 2002 |
| Location | Israel |
| Headquarters | 132 Azrieli Towers Round Building |
| Employees | 5 |
| Sector | Health Care |
| Industries | |
Description
Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email